Biotech startup seeks direct route to pharma collaborators; A hormone therapy for improving cognition in elders?;

Conversations on Twitter :

 @FierceBiotech: Brain signals when 'Special K' will do the trick. More | Follow @FierceBiotech

 @JohnCFierce: Elan now down 12% on bapi fiasco. So does the board have a short list of CEO candidates looking forward to a really tough challenge? | Follow @JohnCFierce

 @RyanMFierce: Not much left at biotech Agennix after talactoferrin failure. More | Follow @RyanMFierce

> Amneal Pharmaceuticals plans to pump $120 million into manufacturing, R&D and distribution facilities spread across New York, New Jersey and Kentucky and create more than 500 jobs. Item

> PharmaEngine will pay up to $56 million in milestone fees to Nanobiotix in an alliance to develop NBTXR3, which is in early-stage development for patients with soft tissue sarcoma. Item

> New York biotech startup Innovimmune aims to bypass venture groups and land an early pact with pharma to develop its pre-IND candidates for inflammatory and autoimmune conditions. Article

> The U.S. defense officials ordered Sarepta Therapeutics to halt work on an Ebola treatment because of funding issues. Item

Pharma News

 @FiercePharma: Endo Health's Q2 profits nosedive on Lidoderm patent litigation charge. More | Follow @FiercePharma

> War-torn Syrian drug plants shut down, triggering shortages. Article

> Researchers eye biomarkers for safer Cox inhibitor use. Story

> WSJ: Top FDA officials knew about email surveillance. Report

> J&J faces new marketing probes as Risperdal settlement nears. More

Medical Device News

@FierceMedDev:The plot thickens in the FDA's surveillance of whistleblowers. More | Follow @FierceMedDev

 @MarkHFierce: Check out the latest preclinical breakthrough news at FierceBiotechResearch. | Follow @MarkHFierce

 @DamianFierce: Mindray Medical rides across-the-board sales growth to a big Q2. More | Follow @DamianFierce

> Device exec canned over Chick-fil-A outburst. More

> Cochlear profit plummets as firm plans implant relaunch. Story

> Sunshine Heart snags conditional approval for pump. Article

Biotech Research News

> Epilepsy drug boosts brain function in Alzheimer's preclinical tests. News

> HIV viral fragment delivers promising acute liver-failure treatment. Story

> Isis Pharmaceuticals' 'anti-sense' drug combats muscular dystrophy mice. More

> Teva's MLK inhibitor blocks aggressive breast cancer in MSU study. Article

Pharma Manufacturing News

> Manufacturing, pricing problems lead to K-V bankruptcy. Item

> Amneal doubling U.S. capacity, to add 500 jobs. News

> China sweeps in on drug counterfeiters. Report

> Fuji buys DKSH Thailand plant for $53M. News

And Finally… Theratechnologies' hormone drug improved executive function and verbal memory in older patients. Article

Suggested Articles

Harvard University scientists are teaming up with the Guangzhou Institute of Respiratory Disease with a $115 million boost from China.

Moderna shares shot up a massive 18% after-hours last night on the fairly standard news that it was about to start a drug trial.

NGM's aldafermin beat placebo at reversing liver scarring and inflammation, as well as reducing liver fat buildup in a 78-patient study.